Exercise of Warrants
EDX Medical Group plc announced that a warrant holder has exercised warrants to acquire ordinary shares at an exercise price of 10p per share. Following this exercise, the Company will have 411,844,583 ordinary shares in issue, with newly issued shares expected to be admitted to trading on the Aquis Stock Exchange on March 10, 2026. The company retains 12,100,000 warrants at 10p and 12,500,000 warrants at 20p.
Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes
CAMBRIDGE, UK: EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces that a warrant holder has agreed to exercise their warrants over ordinary shares in EDX Medical, in accordance with the terms of the warrant instrument.
The warrants were issued at an exercise price of 10p per ordinary share to the first warrant holders of TECC Capital plc ("TECC"). EDX Medical Ltd was acquired by TECC via a reverse takeover in 2022, upon which TECC then changed its name to EDX Medical Group plc.
The Company has a remaining 12,100,000 warrants in place with an exercise price of 10p per ordinary share and 12,500,000 with an exercise price of 20p per ordinary share.
Application will be made for the newly issued shares to be admitted to trading on the Aquis Stock Exchange and it is expected that admission will occur on 10 March 2026.
Following this warrant exercise, the Company has 411,844,583 ordinary shares in issue, each share carrying the right to one vote. This figure serves as the denominator for shareholders to calculate their notification requirements under the Financial Conduct Authority's Disclosure and Transparency Rules regarding their interests in the company's share capital.
The directors of EDX Medical accept responsibility for the contents of this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.